Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Clinical and Humoral Risk Factors for Infection
GVHD prophylaxis with sirolimus and low serum neutralizing antibody titers were correlated with increased risk of RSV infection in the early post-transplant period. These results support the role of developing and implementing strategies that boost neutralizing antibody levels to prevent RSV infections in HCT recipients.
Authors
- Jim Boonyaratanakornkit (ORCID: https://orcid.org/0000-0001-5858-2662)
- Annelie G. Clurman (ORCID: https://orcid.org/0000-0001-8299-6734)
- Madeleine Bibby
- Evelyn D. Harris (ORCID: https://orcid.org/0000-0002-9041-3073)
- Masumi Ueda (ORCID: https://orcid.org/0000-0003-2277-1976)
- Hu Xie
- Melanie Rötepohl
- Sara Pernikoff
- Terry Stevens-Ayers
- Guang-Shing Cheng
- Nina Galanter
- Michael J Boeckh
- Janet A Englund
Institutions
- University of Washington (US)
- Fred Hutch Cancer Center (US)
- Seattle Children's Hospital (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1093/ofid/ofag005
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00